• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Anadys Pharmaceuticals

Anadys Pharmaceuticals

  1. ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer

    ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.